Search Results - scott+raskin

1 Results Sort By:
Immunotherapies Targeting SSX2 Peptide Displayed by MHC on Tumors
­Chimeric Antigen Receptor (CAR) T cells are making headlines with their recent FDA approvals and ability to eradicate cancers. Most CAR T therapies target tumor cells via a tumor associated antigen (TAA). Unfortunately, TAAs are also expressed on non-cancerous tissues, leading to significant risk for patients. SSX2 protein expression is restricted...
Published: 7/30/2024   |   Inventor(s): Eric Yvon, Catherine Bollard, Stacey Van Pelt, Scott Raskin, Gerhard Held, Christine Sturm, Michael Pfreundschuh
Keywords(s):  
Category(s): Technology Classifications > Therapeutics > Proteins and Peptides